Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal

Condition(s) targeted: Hypercholesterolemia

Phase: Phase 4

Status: Completed

Sponsored by: AstraZeneca

Official(s) and/or principal investigator(s):
AstraZeneca Netherlands Medical Director, MD, Study Director, Affiliation: AstraZeneca

The purpose of this study is to determine the efficacy of Crestor in high risk patients switched from higher doses of other statins in obtaining the new European Atherosclerosis Society (EAS) low-density lipoprotein cholesterol (LDL-C) guidelines.

Official title: REALISTIC: Protocol for an Observational Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New EAS LDL-C Target Goal

Study design: Prospective

Minimum age: 18 Years. Maximum age: 70 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- High risk patients

- High doses of other statins

- LDL-C known, starts with Crestor 10 mg

- Permission to use patient data by AstraZeneca (AZ)

Research Site, ALKMAAR, Netherlands

Research Site, ALMELO, Netherlands

Research Site, ALPHEN AAN DEN RIJN, Netherlands

Research Site, AMSTERDAM, Netherlands

Research Site, APELDOORN, Netherlands

Research Site, ASSEN, Netherlands

Research Site, BERGEN OP ZOOM, Netherlands

Research Site, BEVERWIJK, Netherlands

Research Site, BILTHOVEN, Netherlands

Research Site, BLARICUM, Netherlands

Research Site, BOXMEER, Netherlands

Research Site, BREDA, Netherlands

Research Site, BRUNSSUM, Netherlands

Research Site, CAPELLE AAN DEN IJSSEL, Netherlands

Research Site, DELFT, Netherlands

Research Site, DELFZIJL, Netherlands

Research Site, DEN HELDER, Netherlands

Research Site, DIRKSLAND, Netherlands

Research Site, DOETINCHEM, Netherlands

Research Site, DOKKUM, Netherlands

Research Site, DORDRECHT, Netherlands

Research Site, DRACHTEN, Netherlands

Research Site, EDE GLD, Netherlands

Research Site, EINDHOVEN, Netherlands

Research Site, EMMEN, Netherlands

Research Site, ENSCHEDE, Netherlands

Research Site, ETTEN-LEUR, Netherlands

Research Site, GELDROP, Netherlands

Research Site, GOUDA, Netherlands

Research Site, GRONINGEN, Netherlands

Research Site, HAARLEM, Netherlands

Research Site, HARDENBERG, Netherlands

Research Site, HEERENVEEN, Netherlands

Research Site, HEERLEN, Netherlands

Research Site, HELMOND, Netherlands

Research Site, HENGELO OV, Netherlands

Research Site, HOOFDDORP, Netherlands

Research Site, HOOGEVEEN, Netherlands

Research Site, HOORN NH, Netherlands

Research Site, IJMUIDEN, Netherlands

Research Site, LANDSMEER, Netherlands

Research Site, LEIDEN, Netherlands

Research Site, LELYSTAD, Netherlands

Research Site, MAASTRICHT, Netherlands

Research Site, MEPPEL, Netherlands

Research Site, OOSTERHOUT NB, Netherlands

Research Site, OSS, Netherlands

Research Site, PURMEREND, Netherlands

Research Site, ROERMOND, Netherlands

Research Site, ROOSENDAAL, Netherlands

Research Site, ROTTERDAM, Netherlands

Research Site, SCHIEDAM, Netherlands

Research Site, S-GRAVENHAGE, Netherlands

Research Site, S-HERTOGENBOSCH, Netherlands

Research Site, SNEEK, Netherlands

Research Site, SPIJKENISSE, Netherlands

Research Site, STADSKANAAL, Netherlands

Research Site, TERNEUZEN, Netherlands

Research Site, TIEL, Netherlands

Research Site, TILBURG, Netherlands

Research Site, UTRECHT, Netherlands

Research Site, VEGHEL, Netherlands

Research Site, VELDHOVEN, Netherlands

Research Site, VENLO, Netherlands

Research Site, VLAARDINGEN, Netherlands

Research Site, VLISSINGEN, Netherlands

Research Site, WAALWIJK, Netherlands

Research Site, WEERT, Netherlands

Research Site, WINSCHOTEN, Netherlands

Research Site, WINTERSWIJK, Netherlands

Research Site, ZAANDAM, Netherlands

Research Site, ZEVENAAR, Netherlands

Research Site, ZOETERMEER, Netherlands

Research Site, ZUTPHEN, Netherlands

Research Site, ZWOLLE, Netherlands

Starting date: September 2004
Last updated: February 6, 2008